# A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)

> **NCT00231790** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 848 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** MK-0634 50 mg
- **DRUG:** MK-0634 125 mg
- **DRUG:** Placebo for MK-0634

## Key facts

- **NCT ID:** NCT00231790
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-09
- **Final completion:** 2006-10
- **Target enrollment:** 848 (ACTUAL)
- **Last updated:** 2015-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231790, "A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00231790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*